Bob joined Switch Therapeutics in 2020 and is currently the Vice President, Medicinal Chemistry. Bob completed postdoctoral research on mechanistic studies of Drug-DNA interactions at Johns Hopkins University. He received a Bachelor & Master of Science degrees in Chemistry from the University of Pittsburgh and a PhD in Organic Chemistry from the University of Virginia. He is a seasoned leader in the biopharmaceutical industry, with global experience in various chemistry, manufacturing and controls (CMC) functions across R&D and technical operations. He brings a strong scientific and industry background, breadth and depth in many different aspects of research, experience in leading technical operation groups in the strategic development, production, and distribution of diverse and complex biological products on a worldwide basis with a strong quality and regulatory background.
Sign up to view 0 direct reports
Get started